Impressões digitais para diagnóstico em saúde: validação de protótipo de escaneamento informatizado
Using fingerprints for health diagnosis: computerised scanning validation
Palabras clave:
Dermatoglifia, diagnóstico, validação de software (pt)Dermatoglyphics, diagnosis, software validation (en)
Descargas
Objetivo. Validar protótipo de escaneamento informatizado de impressões digitais como instrumento nos diagnósticos em saúde.
Materiais e Métodos. Amostra de n=15 indivíduos, sendo dois avaliadores X dois métodos X amostra. Utilizou-se o protocolo de Cummins e Midlo pelos métodos: Informatizado (M1) e Tradicional (M2).
Resultados. M1 apresenta uma capacidade maior de identificação quantitativa do número de linhas. M1 é mais eficiente, potencializando o nível de assertividade. Não houve diferença significativa entre as observações dos avaliadores intra (M1 x M2) e inter (Avaliador 1 x Avaliador 2), demonstrando a capacidade de reprodutibilidade e confiabilidade do M1. Na comparação das variações internas dos dois métodos, existem diferenças significativas entre os valores médios dos quadrados das diferenças inter-avaliadores, M2 apresenta amplitude 4 vezes maior.
Conclusão. Demonstra-se a eficiência do M1 no processamento das imagens do marcador genéticoimpressão digital, validando o protótipo informatizado como instrumento no diagnóstico em saúde.
Objective. Validating the computerised scanning of fingerprints as a health diagnosis instrument.
Materials and methods. A sample of n=15 individuals, two investigators X and two sample methods X. Cummins and Midlo's protocol was used as follows: computerized (M1) and traditional (M2).
Results. M1 had greater quantitative capacity for identifying the number of lines. M1 was more efficient, having a higher level of positivity. There was no significant difference between intra- (M1 and M2) and inter-investigator (investigator 1 x investigator 2) observations, thereby showing M1 reproducibility and reliability. There were significant differences between the mean values of the squares of inter-investigator differences (M2's amplitude was 4 times greater).
Conclusion. The results showed the efficiency of M1 in processing genetic marker imagesfingerprints, thus validating the computerized prototype as a diagnostic instrument health instrument.
Referencias
Barnetche JM. La bioinformática como herramienta para la investigación en salud humana. salud publica mex 2007;64 - 6.
Taylor AL. Globalization and biotechnology: UNESCO and an international strategy to advance human rights and public health. Am J Law Med. 1999;25(4):479-541.
Heitman E. Ethical issues in technology assessment. Conceptual categories and procedural considerations. Int J Technol Assess Health Care. 1998 Summer;14(3):544-66.
Gupta UK, Prakash S. Dermatoglyphics: a study of finger tip patterns in bronchial asthma and its genetic disposition. Kathmandu Univ Med J (KUMJ). 2003 Oct-Dec;1(4):267-71.
Compton MT. Considering schizophrenia from a prevention perspective. Am J Prev Med. 2004 Feb;26(2):178-85.
Cvjeticanin M, Jajic Z, Jajic I. A contribution to genetic etiology of complex regional pain syndrome type I (algodystropy syndrome) based on quantitative analysis of digitopalmar dermatoglyphics in sixty men. Reumatizam. 2005;52(1):7-11.
Cummins H, Midlo C. Finger Prints, Palmas, and Soles: An Introduction to Dermatoglyphics. New York: Dover Publication 1961.
Abramova TF, Nikitina TM, Izaak SI, Kochetkova NI. Asymmetry of signs of finger dermatoglyphics, physical potential and physical qualities of a man. Morfologiia. 2000;118(5):56-9.
Zivanovic-Posilovic G, Milicic J, Bozicevic D. Dermatoglyphs and gastric cancer. Coll Antropol. 2003 Jun;27(1):213-9.
Chintamani, Khandelwal R, Mittal A, Saijanani S, Tuteja A, Bansal A, et al. Qualitative and quantitative dermatoglyphic traits in patients with breast cancer: a prospective clinical study. BMC Cancer. 2007;7:44.
Rajangam S, Janakiram S, Thomas IM. Dermatoglyphics in Down's syndrome. J Indian Med Assoc. 1995 Jan;93(1):10-3.
Cvjeticanin M, Polovina A. Quantitative analysis of digitopalmar dermatoglyphics in male children with central nervous system lesion by quantification of clinical parameters of locomotor disorder. Acta Med Croatica. 1999;53(1):5-10.
Araujo MECd, Pasquali L. Datiloscopia: A determinação dos dedos. 1 ed. Brasília; 2006.
WMA. World Medical Association. Declaration of Helsinki. Ethical principles for medical research involving human subjects. Adopted by the 18th World Medical Assembly. Helsinki, Finland, June 1964 and amended by 1975, 1983, 1989, 1996, 2000,2004. 2004 9 october 2004; [Internet] Available from: www.wma.net/e/policy/b3.htm Cited 2007 15 august.
MS. Ministério da Saúde. Conselho Nacional de Saúde. Resolução no. 196/96 sobre pesquisa envolvendo seres humanos. Bioética. 1996; 4 Suppl:15-25.
Mendoza HL. Nuevas tecnologías para la investigación de enfermedades infecciosas. Salud Pública Mex. 2007;59-59.
Stempsey WE. Emerging medical technologies and emerging conceptions of health. Theor Med Bioeth. 2006;27(3):227-43.
INCA INdC. I Seminário Sobre Biotecnologia e Ciência: Realidade e Ficção. Rio de Janeiro: Revista Brasileira de Cancerologia; 2005.
Carvalho Td. Diretriz de reabilitação cardiopulmonar e metabólica: Aspectos práticos e responsabilidades. Arquivos Brasileiros de Cardiologia. 2006 Janeiro;86(1):74-82.
Bernacki SH, Farkas DH, Shi W, Chan V, Liu Y, Beck JC, et al. Bioelectronic sensor technology for detection of cystic fibrosis and hereditary hemochromatosis mutations. Archives Of Pathology & Laboratory Medicine. 2003;127(12):1565-72.
Khan HA. CalcNTCP: A simple tool for computation of normal tissue complication probability (NTCP) associated with cancer radiotherapy. Int J Radiat Biol. 2007 Oct;83(10):717-20.
Chakravarti A, Blanton S, Kendall BJ, McCallum RW. Cosegregation of familial intestinal pseudoobstruction and presence of digital arches in a large multigenerational pedigree. Dig Dis Sci. 1996 Jul;41(7):1429-33.
Lopuszanska M, Jankowska EA. Dermatoglyphic morphology in some diseases. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego. 2001;11(63):282-6.
Hoskins KF, Zwaagstra A, Ranz M. Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening. Cancer. 2006 Oct 15;107(8):1769-76.
Cómo citar
APA
ACM
ACS
ABNT
Chicago
Harvard
IEEE
MLA
Turabian
Vancouver
Descargar cita
Visitas a la página del resumen del artículo
Descargas
Licencia

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Esta revista provee acceso libre inmediato a su contenido bajo el principio de que hacer disponible gratuitamente investigación al publico apoya a un mayor intercambio de conocimiento global.
Todos los contenidos de esta revista, excepto dónde está identificado, están publicados bajo una Licencia Creative Commons Atribución 4.0.








